Administering a cholesterol-lowering drug prior to heart bypass surgery or surgical repair of a faulty heart valve may reduce the occurrence of atrial fibrillation, a common heart rhythm disturbance triggered by these surgeries. The research was published in “Circulation: Journal of the American Heart Association.”
Cordis Corp. has launched the CYPHER SELECT Plus Stent, the first third-generation DES, in Western and Eastern Europe ...
Drugs traditionally used for the treatment of gastric ulcers could have therapeutic potential in chronic heart failure, according to new research coming out of Japan. One outcome showed that famotidine appears to reduce left ventricular end-diastolic (LVD-d) and end-systolic (LVD) lengths and reduce BNP (B-type natriuretic peptide) levels.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Siemens Medical Solutions has released the 4.0 ACUSON Antares ultrasound system, premium edition. Antares 4.0 will ...
IMV ServiceTrak ranked GE Healthcare No. 1 for CT and MR Service in a comparison against five other manufacturers of the ...
The Federal Communications Commission (FCC) plans to create a pilot program that will help public and nonprofit healthcare providers establish state and regional broadband networks dedicated to healthcare services, as well as provide funding for these networks to connect to Internet2’s nationwide advanced research and education network.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Johnson & Johnson has filed a $5.5 billion lawsuit against Guidant Corp. in U.S. District Court in New York, claiming that Guidant leaked confidential information to Abbott Laboratories to secure a crucial component of the deal with Boston Scientific, reports Modernhealthcare.com.
Two of the six astronauts from the shuttle mission Atlantis became part of an ongoing cardiovascular study at NASA about ...
Enrollment is complete for a landmark study designed to increase clinical understanding of vulnerable plaque, the deadly, lipid-rich coronary plaque that ruptures without warning or symptoms and possibly the source of most heart attacks.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Plus, underuse of aspirin after stent is “a travesty” says Mayo doctor Cardiologists were urged to halt the "epidemic of madness" behind drug-eluting stent (DES) overuse, during an address by Salim Yusuf, M.D., McMaster University, Hamilton, Ontario, at the World Congress of Cardiology in Barcelona.
Positive six-month results of Abbott's SPIRIT II clinical trial of the XIENCE V Everolimus Eluting Coronary Stent System were presented at the World Congress of Cardiology conference in Barcelona, Spain. XIENCE V, which has received CE Mark approval, is currently an investigational device in the U.S. and Japan — Abbott says it plans to initiate European launch of the coronary DES in October.
Thousands of lives potentially saved and hospital costs reduced are the predicted outcomes if more hospitals adopt certain quality measures on a wider scale, according to an analysis by Premier Inc. healthcare alliance, headquartered in San Diego, which is owned by more than 200 of the nation's leading not-for-profit hospitals and healthcare systems.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Siemens completed its acquisition of Diagnostic Products Corp. (DPC) in late July, marking a significant milestone for Siemens as it enters the in-vitro diagnostics (IVD) market. Together with DPC, Siemens Medical Solutions says it will become the first full service diagnostics company.
GE Healthcare and Volcano Corp. have announced FDA 510(k) clearance for the integration of Volcano’s intravascular ultrasound imaging (IVUS) capabilities onto the best-of-class Innova all-digital X-ray cath lab imaging system
New SPECT/CT, cardiovascular IT and PET/CT technologies were on display by Philips Medical Systems at the American Society of Nuclear Cardiology (ASNC) annual meeting in Montreal.